Teva is divesting Teva Takeda, its joint venture with Takeda Pharmaceutical in Japan, as it seeks to focus on bringing innovative medicines to the Japanese market.
Teva Divests Takeda JV, Pivots To Innovative Drugs In Japan
Takeda Expects $365m Payment
The divestment decision comes years after it slimmed down amid challenges in the Japanese generic market.
